Start / All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier / Episode 52 drug survivability of omalizumab in chronic urticaria

All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier

Episode 52 - Drug Survivability of Omalizumab in Chronic Urticaria

22 min • 12 december 2022

Dr Heike Röckmann, head of the drug survivability of omalizumab in chronic urticaria (DruSO-CU) project joins Professor Marcus Maurer to discuss the global project, the difficulties which were encountered, and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.

Senaste avsnitt

Urticaria in Children: Diagnosis, Triggers & Treatment

12 augusti | 20 min

Itch & Urticaria: Mechanisms, Misconceptions & Hope

15 juli | 22 min

Females, Pregnancy & Chronic Urticaria: What Doctors Should Know

17 juni | 19 min

The spectrum of cold urticaria

20 maj | 21 min

Urticaria Tracking with CRUSE: A Game-Changer for Patients & Research

22 april | 16 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00